$YTENQ
YIELD10 BIOSCIENCE, INC.

2012 Q4 Form 10-Q Financial Statement

#000110465912075292 Filed on November 07, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $1.397M $674.0K $469.0K
YoY Change 218.22% 43.71% 919.57%
Cost Of Revenue $620.0K $316.0K $0.00
YoY Change
Gross Profit $780.0K $358.0K $470.0K
YoY Change -23.83%
Gross Profit Margin 55.83% 53.12% 100.21%
Selling, General & Admin $3.520M $3.170M $3.895M
YoY Change -11.11% -18.61% -6.39%
% of Gross Profit 451.28% 885.47% 828.72%
Research & Development $7.200M $4.930M $6.150M
YoY Change 18.23% -19.84% 4.06%
% of Gross Profit 923.08% 1377.09% 1308.51%
Depreciation & Amortization $270.0K $310.0K $360.0K
YoY Change -28.95% -13.89% -7.69%
% of Gross Profit 34.62% 86.59% 76.6%
Operating Expenses $10.30M $3.170M $3.895M
YoY Change 2.39% -18.61% -6.39%
Operating Profit -$9.520M -$7.743M -$9.579M
YoY Change -1.01% -19.17% -4.41%
Interest Expense $100.0K $27.00K $19.00K
YoY Change 900.0% 42.11% -36.67%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$2.000K
YoY Change
Pretax Income -$9.520M -$7.750M -$9.560M
YoY Change -0.83% -18.93% -4.3%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.520M -$7.750M -$9.560M
YoY Change -0.83% -18.93% -4.3%
Net Earnings / Revenue -681.46% -1149.85% -2038.38%
Basic Earnings Per Share -$0.28 -$0.23 -$0.28
Diluted Earnings Per Share -$0.28 -$0.23 -$0.28
COMMON SHARES
Basic Shares Outstanding 34.31M shares 34.24M shares 34.08M shares
Diluted Shares Outstanding 34.24M shares 34.08M shares

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.80M $47.80M $72.70M
YoY Change -43.04% -34.25% 4.01%
Cash & Equivalents $14.57M $17.41M $17.39M
Short-Term Investments $29.20M $30.40M $55.30M
Other Short-Term Assets $700.0K $700.0K $500.0K
YoY Change -12.5% 40.0% 25.0%
Inventory $3.204M $3.028M
Prepaid Expenses
Receivables $839.0K $654.0K $800.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $48.96M $52.88M $73.93M
YoY Change -37.59% -28.48% 4.42%
LONG-TERM ASSETS
Property, Plant & Equipment $1.358M $1.634M $2.300M
YoY Change -40.33% -28.96% -25.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.500M $5.800M $14.50M
YoY Change 66.67% -60.0%
Other Assets $95.00K $95.00K $700.0K
YoY Change 31.94% -86.43% 0.0%
Total Long-Term Assets $4.555M $8.090M $17.48M
YoY Change 1.83% -53.71% 359.89%
TOTAL ASSETS
Total Short-Term Assets $48.96M $52.88M $73.93M
Total Long-Term Assets $4.555M $8.090M $17.48M
Total Assets $53.51M $60.97M $91.41M
YoY Change -35.46% -33.3% 22.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.233M $240.0K $500.0K
YoY Change 140.82% -52.0%
Accrued Expenses $3.519M $3.500M $3.600M
YoY Change -1.54% -2.78% -18.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.984M $4.852M $6.957M
YoY Change -16.48% -30.26% -2.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $131.0K $128.0K $36.60M
YoY Change 10.08% -99.65% 2.23%
Total Long-Term Liabilities $131.0K $128.0K $36.60M
YoY Change 10.08% -99.65% 2.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.984M $4.852M $6.957M
Total Long-Term Liabilities $131.0K $128.0K $36.60M
Total Liabilities $6.170M $5.077M $43.54M
YoY Change -85.8% -88.34% 1.72%
SHAREHOLDERS EQUITY
Retained Earnings -$242.0M -$232.5M
YoY Change -1.48%
Common Stock $289.4M $288.4M
YoY Change 1.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.34M $55.89M $47.90M
YoY Change
Total Liabilities & Shareholders Equity $53.51M $60.97M $91.41M
YoY Change -35.46% -33.3% 22.53%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$9.520M -$7.750M -$9.560M
YoY Change -0.83% -18.93% -4.3%
Depreciation, Depletion And Amortization $270.0K $310.0K $360.0K
YoY Change -28.95% -13.89% -7.69%
Cash From Operating Activities -$7.320M -$6.280M -$7.820M
YoY Change -14.98% -19.69% 10.3%
INVESTING ACTIVITIES
Capital Expenditures $10.00K -$110.0K -$140.0K
YoY Change -103.7% -21.43% -53.33%
Acquisitions
YoY Change
Other Investing Activities $4.480M $11.66M $5.580M
YoY Change -64.92% 108.96% -25.5%
Cash From Investing Activities $4.480M $11.55M $5.450M
YoY Change -64.13% 111.93% -24.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 -10.00K
YoY Change -100.0% -100.0% -105.88%
NET CHANGE
Cash From Operating Activities -7.320M -6.280M -7.820M
Cash From Investing Activities 4.480M 11.55M 5.450M
Cash From Financing Activities 0.000 0.000 -10.00K
Net Change In Cash -2.840M 5.270M -2.380M
YoY Change -173.01% -321.43% -981.48%
FREE CASH FLOW
Cash From Operating Activities -$7.320M -$6.280M -$7.820M
Capital Expenditures $10.00K -$110.0K -$140.0K
Free Cash Flow -$7.330M -$6.170M -$7.680M
YoY Change -12.11% -19.66% 13.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Inventory Net
InventoryNet
3028000 USD
CY2011Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
304000 USD
CY2011Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
185000 USD
CY2012Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
200000 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1740000 USD
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2141000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12526000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17392000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7745000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
119000 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
35944000 USD
CY2011Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
221000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7165000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2914000 USD
CY2011Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
165000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
512000 USD
CY2011Q4 us-gaap Assets
Assets
82912000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72000 USD
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
1503000 USD
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34243792 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34270455 shares
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2276000 USD
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
622000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
78439000 USD
CY2011Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
311000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146000 USD
CY2012Q3 us-gaap Assets
Assets
60969000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82912000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24424000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34188146 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3028000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
55578000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21277000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-429000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
88000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
448000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
93888000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
627000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4852000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-3872000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20535000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13147000 USD
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34243792 shares
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60969000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
55892000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
12000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
5077000 USD
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34115798 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
39463000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-245662000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
284796000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
341000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
43449000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
4866000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-11000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
49404000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
49333000 USD
mblx Proceeds From Options And Warrants Exercised
ProceedsFromOptionsAndWarrantsExercised
71000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21403000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
73112000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-23124000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1335000 USD
mblx Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-115000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-541000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3574000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
489000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1134000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29182000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7743000 USD
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
8417000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-28000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
674000 USD
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34080177 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34080177 shares
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9560000 USD
CY2011Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
19000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9579000 USD
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
10048000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3895000 USD
CY2011Q3 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
6153000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Amendment Flag
AmendmentFlag
false
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
24000 USD
CY2011Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12000 USD
CY2011Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
26000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-29244000 USD
us-gaap Costs And Expenses
CostsAndExpenses
30230000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11878000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
18352000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
986000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
419000 USD
CY2011Q3 us-gaap Revenue From Grants
RevenueFromGrants
443000 USD
us-gaap Revenue From Grants
RevenueFromGrants
567000 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
469000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
13123000 USD
us-gaap Costs And Expenses
CostsAndExpenses
27796000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
316000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
40919000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
457000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30295881 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30295881 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
62000 USD
dei Entity Registrant Name
EntityRegistrantName
METABOLIX, INC.
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2360000 USD
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34250180 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34115798 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0095 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0067 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0238 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0115 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.80 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.87 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.77 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84 pure
CY2012Q3 us-gaap Assets Current
AssetsCurrent
52879000 USD
CY2011Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
49333000 USD
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5669132 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5417159 shares
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3834238 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3834238 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.14
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.84
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.65
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.15
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.36
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2756107 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5665046 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
675303 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11436 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2493100 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3858685 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.47
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1126000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3566000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
852000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2954000 USD
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6533000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y5M1D
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3574000 USD
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1409000 USD
CY2011Q4 mblx Accrued Intellectual Property Current
AccruedIntellectualPropertyCurrent
240000 USD
CY2012Q3 mblx Accrued Intellectual Property Current
AccruedIntellectualPropertyCurrent
150000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8000 USD
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34306570 shares
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-17000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7730000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9565000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13139000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29199000 USD
CY2011Q4 mblx Operating Loss Carryforwards Attributable To Deduction Related To Exercise Of Stock Options
OperatingLossCarryforwardsAttributableToDeductionRelatedToExerciseOfStockOptions
19201000 USD
CY2011Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7130000 shares
CY2011Q2 mblx Common Stock Issue Price Per Share
CommonStockIssuePricePerShare
7.25
CY2011Q2 mblx Common Stock Issuances Underwriting Discounts Commissions And Offering Costs
CommonStockIssuancesUnderwritingDiscountsCommissionsAndOfferingCosts
2360000 USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34250180 shares
us-gaap Cost Of Goods Sold
CostOfGoodsSold
808000 USD
CY2011Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82309 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
82309 shares
CY2012Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
806000 USD
CY2012Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8000 USD
CY2012Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2214000 USD
us-gaap Restructuring And Related Cost Cost Incurred To Date
RestructuringAndRelatedCostCostIncurredToDate
920000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
61000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
920000 USD
mblx Maximum Period To Audit For Loss
MaximumPeriodToAuditForLoss
P3Y
mblx Revenue Recognition Period For Which Limited Right Of Return Provided To Customers
RevenueRecognitionPeriodForWhichLimitedRightOfReturnProvidedToCustomers
P60D
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
30418000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
654000 USD
CY2012Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
667000 USD
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
707000 USD
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
594000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1634000 USD
CY2012Q3 us-gaap Long Term Investments
LongTermInvestments
5767000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
240000 USD
CY2012Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
165000 USD
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
959000 USD
CY2012Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
97000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
128000 USD
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
343000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
288084000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-232515000 USD
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
576000 USD
CY2012Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
28000 USD
CY2012Q3 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4931000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3170000 USD
CY2012Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
mblx Revenue From Termination Of Collaboration With Subsidiary
RevenueFromTerminationOfCollaborationWithSubsidiary
38885000 USD
us-gaap Revenue From Grants
RevenueFromGrants
1415000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
162000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
15982000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11006000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000 USD
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1026000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
350000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2935000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
871000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-311000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-94000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-272000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-101000 USD
mblx Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-115000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-37900000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
397000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
56428000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
77320000 USD
mblx Proceeds From Options And Warrants Exercised
ProceedsFromOptionsAndWarrantsExercised
19000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
859000 USD
us-gaap Use Of Estimates
UseOfEstimates
<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman',times,serif"> <tr> <td> <p style="MARGIN: 0in 0in 0pt">&#160;</p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 26pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></p></td></tr></table></td></tr></table>
CY2012Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
36175000 USD
CY2011Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
57066000 USD
us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
12000 USD
CY2011 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
18000 USD
us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
2000 USD
CY2011 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
3000 USD
CY2012Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
36185000 USD
CY2011Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
57081000 USD
mblx Long Term Investments Maximum Maturity Period
LongTermInvestmentsMaximumMaturityPeriod
P2Y

Files In Submission

Name View Source Status
0001104659-12-075292-index-headers.html Edgar Link pending
0001104659-12-075292-index.html Edgar Link pending
0001104659-12-075292.txt Edgar Link pending
0001104659-12-075292-xbrl.zip Edgar Link pending
a12-20062_110q.htm Edgar Link pending
a12-20062_1ex31d1.htm Edgar Link pending
a12-20062_1ex31d2.htm Edgar Link pending
a12-20062_1ex32d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mblx-20120930.xml Edgar Link completed
mblx-20120930.xsd Edgar Link pending
mblx-20120930_cal.xml Edgar Link unprocessable
mblx-20120930_def.xml Edgar Link unprocessable
mblx-20120930_lab.xml Edgar Link unprocessable
mblx-20120930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending